BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Sultamicillin tosylate | Sultamicillin is a compound composed of sulbactam and ampicillin linked as a double ester. Sulbactam is a semisynthetic beta-lactamase inhibitor, which exhibits improved antibacterial activity in combination with ampicillin. Group: Pharmaceutical. Alternative Names: Bacimex; Unacim orale. CAS No. 83105-70-8. Pack Sizes: 500 mg. Product ID: B0001-078090. Molecular formula: C32H38N4O12S3. Mole weight: 766.86. Custom synthesis is available. Send your inquiries for more information. |  London |
| Sumatriptan succinate | Sumatriptan Succinate is a triptan sulfa drug containing a sulfonamide group for the treatment of migraine headaches. Uses: Vasoconstrictor agents. Group: Pharmaceutical. Alternative Names: Imigran; Imitrex; Sumitrex; Arcoiran; GR 43175; GR43175; GR-4317; 3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide Succinate. CAS No. 103628-48-4. Pack Sizes: 1 g. Product ID: B1370-053376. Molecular formula: C18H27N3O6S. Mole weight: 413.49. Custom synthesis is available. Send your inquiries for more information. | London |
| SUN11602 | SUN11602 is a novel aniline compound, which mimics the neuroprotective mechanisms of basic fibroblast growth factor. In primary cultures of rat cerebrocortical neurons, SUN11602 and bFGF prevented glutamate-induced neuronal death. Group: Pharmaceutical. Alternative Names: SUN11602; SUN-11602; SUN 11602. 4-[[4-[[2-(4-amino-2,3,5,6-tetramethylanilino)acetyl]-methylamino]piperidin-1-yl]methyl]benzamide. CAS No. 704869-38-5. Pack Sizes: 100 mg. Product ID: B0084-462595. Molecular formula: C26H37N5O2. Mole weight: 451.615. Custom synthesis is available. Send your inquiries for more information. | London |
| Sunitinib | Sunitinib is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit. Uses: Angiogenesis inhibitors; antineoplastic agents. Group: Pharmaceutical. Alternative Names: SU11248; SU 11248; SU-11248. CAS No. 557795-19-4. Pack Sizes: 2.5 g. Product ID: B0084-186154. Molecular formula: C22H27FN4O2. Mole weight: 398.47. Custom synthesis is available. Send your inquiries for more information. | London |
| Sunitinib-[d10] | One of the isotopic labelled form of Sunitinib, which is a receptor tyrosine kinases inhibitor. Group: Pharmaceutical. Alternative Names: N-[2-(Diethyl-d10)aminoethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide; Sutent-d10; SU-11248-d10. CAS No. 1126721-82-1. Pack Sizes: 25 mg. Product ID: BLP-013107. Molecular formula: C22H17D10FN4O2. Mole weight: 408.47. Custom synthesis is available. Send your inquiries for more information. | London |
| Sunitinib malate | Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications. Uses: Angiogenesis inhibitors. Group: Pharmaceutical. Alternative Names: Sunitinib malate; SU011248 L-malate salt; N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;(2S)-2-hydroxybutanedioic acid. CAS No. 341031-54-7. Pack Sizes: 1 g. Product ID: NP3249. Molecular formula: C22H27FN4O2.C4H6O5. Mole weight: 532.56. Custom synthesis is available. Send your inquiries for more information. | London |
| Sutezolid | Sutezolid, also called as PNU-100480, is an oxazolidinone antibacterial compound to reach Phase-II clinical research for Tuberculosis. Group: Pharmaceutical. Alternative Names: N-[[(5S)-3-(3-fluoro-4-thiomorpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamidePF-02341272; PF02341272; PF 02341272; PNU-100480; PNU 100480; PNU100480; U-100480; U 100480; U100480; Sutezolid.168828-58-8. CAS No. 168828-58-8. Pack Sizes: 25 mg. Product ID: B0084-458614. Molecular formula: C16H20FN3O3S. Mole weight: 353.41. Custom synthesis is available. Send your inquiries for more information. | London |
| Suxibuzone | Suxibuzone, abbreviated to SBZ, a prodrug of the non steroidal anti inflammatory drug Phenylbutazone, is a NSAID derived from PBZ, which was designed to produce less gastric irritation. In experimental animals, it has been demonstrated that it has a simil. Group: Pharmaceutical. Alternative Names: 4-BUTYL-4-[HYDROXYMETHYL]-1,2-DIPHENYL-3,5-PYRAZOLIDINEDIONE HYDROGEN SUCCINATE [ESTER];SUXIBUZONE;4-butyl-4-(beta-carboxypropionyl-oxymethyl)-1,2-diphenyl-3,5-pyrazolidinedio;4-butyl-4-hydroxymethyl-1,2-diphenyl-3,5-pyrazolidinedionehydrogensuccinate;ae. CAS No. 27470-51-5. Pack Sizes: 1mg;1g;10g. Product ID: 27470-51-5. Molecular formula: C24H26N2O6. Mole weight: 438.47. Custom synthesis is available. Send your inquiries for more information. | London |
| (S)-Viloxazine Hydrochloride | The S-isomer of Viloxazine, a selective norepinephrine reuptake inhibitor (NRI) used as an antidepressant. Uses: The (s)-isomer of. Group: Pharmaceutical. Alternative Names: (2S)-2-[(2-ethoxyphenoxy)methyl]morpholine hydrochloride. CAS No. 56287-61-7. Pack Sizes: 1 g. Product ID: B2694-122081. Molecular formula: C13H20ClNO3. Mole weight: 273.76. Custom synthesis is available. Send your inquiries for more information. | London |
| Swertiamarin | Swertiamarin is isolated from the herbs of Swertia bimaculata. It possesses cytoprotective and immune reactivity abilities. Uses: Antioxidant; hepatoprotective;anti-hyperglycemic, anti-hyperlipidemic, anti-diabetic activity. Group: Pharmaceutical. Alternative Names: Swertiamarine. CAS No. 17388-39-5. Pack Sizes: 250 mg. Product ID: NP3827. Molecular formula: C16H22O10. Mole weight: 374.34. Custom synthesis is available. Send your inquiries for more information. | London |
| Swertianin | Swertianin is found in the herbs of Gentiana bavarica, it has potential anti-inflammatory and antinoceceptive which could be used as a drug candidate against inflammation related conditions. Group: Pharmaceutical. Alternative Names: Gentiakochianin; 1,2,8-Trihydroxy-6-methoxy-9H-xanthen-9-one. CAS No. 20882-75-1. Pack Sizes: 10 mg. Product ID: B2703-409829. Molecular formula: C14H10O6. Mole weight: 274.23. Custom synthesis is available. Send your inquiries for more information. | London |
| Swertiaperennin | Swertiaperennin is a xanthone isolated from Swertia bimaculata. Group: Pharmaceutical. Alternative Names: Methylswertianin; 1,8-Dihydroxy-2,6-dimethoxy-9H-xanthen-9-one; 2-O-Methylswertianin. CAS No. 22172-17-4. Pack Sizes: 5 mg. Product ID: B2703-058328. Molecular formula: C15H12O6. Mole weight: 288.25. Custom synthesis is available. Send your inquiries for more information. | London |
| Swertisin | Swertisin efficiently changed the morphology of NIH3T3 cells from fibroblastic to round aggregate cell cluster in huge numbers. Dithizone (DTZ) stain primarily confirmed differentiation and gene expression studies signified rapid onset of differentiation signaling cascade in Swertisin-induced ILCC. Group: Pharmaceutical. Alternative Names: Flavocommelitin; 6-C-glucopyranosyl-7-O-methylapigenin; Apigenin 6-glucosyl-7-O-methyl ether. CAS No. 6991-10-2. Pack Sizes: 5 mg. Product ID: B2703-199278. Molecular formula: C22H22O10. Mole weight: 446.4. Custom synthesis is available. Send your inquiries for more information. | London |
| Swietemahalactone | Swietemahalactone is an abundantly occurring botanical-derived natural compound boasting potent anti-inflammatory and anticancer characteristics. Group: Pharmaceutical. Alternative Names: methyl (S)-2-((1R,2aS,2a1R,3S,3aR,5aR,6R,9bR,11aS,12S)-6-(furan-3-yl)-2a,11a-dihydroxy-1,3,5a-trimethyl-8,11-dioxo-1,2,2a,2a1,3,3a,4,5,5a,8,11,11a-dodecahydro-6H-1,3-methanofuro[4',3',2':6,1]pentaleno[1,2-f]isochromen-12-yl)-2-hydrox. CAS No. 1514669-21-6. Pack Sizes: 1 mg. Product ID: NP6594. Molecular formula: C27H30O10. Mole weight: 514.52. Custom synthesis is available. Send your inquiries for more information. | London |
| SYBR Green I | SYBR Green I is a fluorescent probe used for staining double stranded DNA or oligonucleotides in agarose or polyacrylamide gels. Group: Pharmaceutical. Alternative Names: Nucleic acid gel stain; 2-((2-((3-(Dimethylamino)propyl)(propyl)amino)-1-phenylquinolin-4(1H)-ylidene)methyl)-3-methylbenzo[d]thiazol-3-ium; 2-[[3-(Dimethylamino)propyl]propylamino]-4-[(3-methyl-2(3H)-benzothiazolylidene)methyl]-1-phenylquinolinium; Sybr Green I; SYBR Green I cation. CAS No. 178918-96-2. Pack Sizes: 50 mg. Product ID: 178918-96-2. Molecular formula: C32H37N4S. Mole weight: 509.73. Custom synthesis is available. Send your inquiries for more information. | London |
| Sylvestroside I | Sylvestroside I is a compound of the iridoids found in Acicarpha tribuloides Juss. Group: Pharmaceutical. Alternative Names: methyl (1S,4aS,6S,7R,7aS)-6-[(2S,3R,4S)-3-ethenyl-4-(2-hydroxyethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-5-carbonyl]oxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate. CAS No. 71431-22-6. Pack Sizes: 5 mg. Product ID: B0005-053294. Molecular formula: C33H48O19. Mole weight: 748.728. Custom synthesis is available. Send your inquiries for more information. | London |
| Synephrine | Synephrine is an α-adrenergic receptor agonist used as a vasoconstrictor. Synephrine is a natural stimulant without any side effects or positive reactions. It is widely used in healthcare industries such as medicine, food, and beverages. Uses: Vasoconstrictor. Group: Pharmaceutical. Alternative Names: Oxedrine; P-Synephrine; Parasympatol; Sympaethamine; rac-Synephrine; (+/-)-Synephrine; 4-[1-hydroxy-2-(methylamino)ethyl]phenol. CAS No. 94-07-5. Pack Sizes: 25 g. Product ID: B0084-325296. Molecular formula: C9H13NO2. Mole weight: 167.21. Custom synthesis is available. Send your inquiries for more information. | London |
| (-)-Syringaresinol | (-)-Syringaresinol is isolated from the rhizomes of Polygonatum kingianum. DL-Syringaresinol inhibits the proliferation of human promyelocytic HL-60 cells through G(1) arrest and induction of apoptosis, may be a potential chemotherapeutic agent for the treatment of cancer. Group: Pharmaceutical. Alternative Names: DL-Syringaresinol; (-)-Lirioresinol B; 4,4'-((1R,3aS,4R,6aS)-Tetrahydro-1H,3H-furo(3,4-C)furan-1,4-diyl)bis(2,6-dimethoxyphenol). CAS No. 6216-81-5. Pack Sizes: 50 mg. Product ID: NP4121. Molecular formula: C22H26O8. Mole weight: 418.44. Custom synthesis is available. Send your inquiries for more information. | London |
| Syringetin-3-O-rutinoside | Syringetin-3-O-rutinoside is found in the leaves of Corylus heterophylla Fisch. Group: Pharmaceutical. Alternative Names: Syringetin-3-O-rutinoside; 53430-50-5; HY-N7889; CS-0138753; 3-[(6-O-alpha-L-Rhamnopyranosyl-beta-D-glucopyranosyl)oxy]-4',5,7-trihydroxy-3',5'-dimethoxyflavone. CAS No. 53430-50-5. Pack Sizes: 10 mg. Product ID: B2703-334824. Molecular formula: C29H34O17. Mole weight: 654.57. Custom synthesis is available. Send your inquiries for more information. | London |
| Syringin pentaacetate | Syringin pentaacetate isolated from the herbs of Liriodendron chinense (Hemsl.) Sarg. Group: Pharmaceutical. Alternative Names: (2E)-3-{3,5-Dimethoxy-4-[(2,3,4,6-tetra-O-acetyl-β-D-glucopyranos yl)oxy]phenyl}-2-propen-1-yl acetate. CAS No. 92233-55-1. Pack Sizes: 1 mg. Product ID: NP5509. Molecular formula: C27H34O14. Mole weight: 582.6. Custom synthesis is available. Send your inquiries for more information. | London |
| Syrosingopine | Syrosingopine is a dual MCT1 and MCT4 inhibitor. Syrosingopine sensitizes cancer cells to metformin, which can be a promising therapeutic strategy for clinical application for the treatment of cancer. Group: Pharmaceutical. Alternative Names: Syringopine; Menatensina; Neoreserpan. CAS No. 84-36-6. Pack Sizes: 10 mg. Product ID: NP0043. Molecular formula: C35H42N2O11. Mole weight: 666.72. Custom synthesis is available. Send your inquiries for more information. | London |
| Syzalterin | Syzalterin is isolated from the herbs of Rhododendron dauricum. Group: Pharmaceutical. Alternative Names: 6,8-Dimethylapigenin. CAS No. 94451-48-6. Pack Sizes: 5 mg. Product ID: NP2163. Molecular formula: C17H14O5. Mole weight: 298.3. Custom synthesis is available. Send your inquiries for more information. | London |
| SZ1676 | SZ1676, a derivative of SZ1677, is a neuromuscular blocking agent. Group: Pharmaceutical. Alternative Names: [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-2-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-10,13-dimethyl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;bromide. CAS No. 159325-23-2. Pack Sizes: 1mg;1g;10g. Product ID: 159325-23-2. Molecular formula: C37H59BrN2O6. Mole weight: 707.78. Custom synthesis is available. Send your inquiries for more information. | London |
| T0901317 | T0901317 is a potent and selective agonist for both LXR and FXR, with EC50 of ~50 nM and 5 μM, respectively. T0901317 induces apoptosis and inhibits the development of atherosclerosis in low-density lipoprotein (LDL) receptor-deficient mice. Group: Pharmaceutical. Alternative Names: T 0901317; T-0901317; TO-901317; TO901317; N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]benzenesulfonamide; T-1317. CAS No. 293754-55-9. Pack Sizes: 300 mg. Product ID: B0084-369166. Molecular formula: C17H12F9NO3S. Mole weight: 481.33. Custom synthesis is available. Send your inquiries for more information. | London |
| T4-acetamide | An impurity of Levothyroxine. Levothyroxine is used to treat hypothyroidism. Group: Pharmaceutical. Alternative Names: 2-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)acetamide; 3,5,3',5'-Tetraiodo Thyroacetamide; 4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzeneacetamide. CAS No. 176258-88-1. Pack Sizes: 100 mg. Product ID: B0136-473784. Molecular formula: C14H9I4NO3. Mole weight: 746.85. Custom synthesis is available. Send your inquiries for more information. | London |
| T-5224 | T-5224 is a selective inhibitor of c-Fos/activator protein-1. T-5224 ameliorates liver injury and improves survival through decreasing production of proinflammatory cytokines and chemokines in endotoxemic mice. T-5224 has been investigated in phase II human clinical trials. T-5224 may be a promising new treatment for septic kidney injury. Activator protein 1 (AP-1) is a pivotal transcription factor that regulates a wide range of cellular processes including proliferation, apoptosis, differentiation, survival, cell migration, and transformation. Accumulating evidence supports that AP-1 plays an important role in several severe disorders including cancer, fibrosis, and organ injury, as well as inflammatory disorders such as asthma, psoriasis, and rheumatoid arthritis. Group: Pharmaceutical. Alternative Names: T5224; T 5224. CAS No. 530141-72-1. Pack Sizes: 100 mg. Product ID: B1370-462792. Molecular formula: C29H27NO8. Mole weight: 517.53. Custom synthesis is available. Send your inquiries for more information. | London |
| T863 | T-863 is an orally active, selective and potent DGAT1 (Acyl-CoA:diacylglycerol acyltransferase 1) inhibitor that interacts with the acyl-CoA binding site of DGAT1, and inhibits triacylglycerol synthesis in cells. It causes weight loss, reduction in serum and liver triglycerides, and improved insulin sensitivity in obese mice. Group: Pharmaceutical. Alternative Names: DGAT-1 inhibitor; DGAT 1 inhibitor; T863; T-863; T 863. CAS No. 701232-20-4. Pack Sizes: 25 mg. Product ID: B2693-131149. Molecular formula: C22H26N4O3. Mole weight: 394.47. Custom synthesis is available. Send your inquiries for more information. | London |
| Tabernanthine | Tabernanthine is an alkaloid isolated from Tabernaemontana hilariana. Tabernanthine can reduce the self-administration of cocaine and morphine in rats. Tabernanthine acts as a benzodiazepine receptor inverse agonist in a discriminant in vitro binding assay. Group: Pharmaceutical. Alternative Names: 13-Methoxyibogamine. CAS No. 83-94-3. Pack Sizes: 1 mg. Product ID: NP0754. Molecular formula: C20H26N2O. Mole weight: 310.441. Custom synthesis is available. Send your inquiries for more information. | London |
| Tabersonine | Tabersonine is a monoterpenoid indole alkaloid found in the beans of Voacanga africana, a plant traditionally used for religious purposes in Africa. Group: Pharmaceutical. Alternative Names: (-)-Tabersonine; Tabersonin; Aspidospermidine-3-carboxylic acid, 2,3,6,7-tetradehydro-, methyl ester, (5α,12R,19α)-; 1H-Indolizino[8,1-cd]carbazole-5-carboxylic acid, 3a-ethyl-3a,4,6,11,12,13a-hexahydro-, methyl ester. CAS No. 4429-63-4. Pack Sizes: 50 mg. Product ID: NP0056. Molecular formula: C21H24N2O2. Mole weight: 336.43. Custom synthesis is available. Send your inquiries for more information. | London |
| Tacalcitol monohydrate | Tacalcitol is a vitamin D analogue that promotes normal bone development by regulating calcium. It modulates immunological and inflammatory processes and induces nerve growth factor production in epidermal keratinocytes. Group: Pharmaceutical. Alternative Names: 1,24(R)-Dihydroxyvitamin D3, monohydrate. CAS No. 93129-94-3. Pack Sizes: 5 mg. Product ID: B2693-100725. Molecular formula: C27H46O4. Mole weight: 434.65. Custom synthesis is available. Send your inquiries for more information. | London |
| Taccalonolide A | Taccalonolide A is a steroid with antimalarial activities. It is effective in vitro against cell lines that overexpress P-glycoprotein (Pgp) and multidrug resistance protein 7 (MRP7), with an IC50 of 622 nM for SK-OV-3 cells. Group: Pharmaceutical. CAS No. 108885-68-3. Pack Sizes: 25 mg. Product ID: B2703-334671. Molecular formula: C36H46O14. Mole weight: 702.74. Custom synthesis is available. Send your inquiries for more information. | London |
| Tachyplesin I | Tachyplesin I, an antimicrobial peptide originally found in the extract of hemocytes from the Japanese horseshoe crab, has antiviral activity against vesicular stomatitis virus, influenza A virus and HIV-1. It belongs to arthropodous peptide antibiotics, and can inhibit the growth of Gram-negative bacteria and positive bacteria, and form a complex with bacterial lipopolysaccharides. Group: Pharmaceutical. Alternative Names: H-Lys-Trp-Cys-Phe-Arg-Val-Cys-Tyr-Arg-Gly-Ile-Cys-Tyr-Arg-Arg-Cys-Arg-NH2 (Disulfide bridge: Cys3-Cys16, Cys7-Cys12); L-lysyl-L-tryptophyl-L-cysteinyl-L-phenylalanyl-L-arginyl-L-valyl-L-cysteinyl-L-tyrosyl-L-arginyl-glycyl-L-isoleucyl-L-cysteinyl-L-tyrosyl-L-arginyl-L-arginyl-L-cysteinyl-L-argininamide (3->16),(7->12)-bis(disulfide); Lipopolysaccharide-binding peptide; Tachyplesin I (Tachypleus tridentatus); Tachyplesin. CAS No. 118231-04-2. Pack Sizes: 1 mg. Product ID: BAT-015165. Molecular formula: C99H151N35O19S4. Mole weight: 2263.74. Custom synthesis is available. Send your inquiries for more information. | London |
| Tacrolimus EP Impurity A | Ascomycin, isolated from Streptomyces, suppresses immune response in vitro with IC50 of 0.55 nM for mouse mixed lymphocyte. Uses: Anti-bacterial agents. Group: Pharmaceutical. Alternative Names: (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-8-ethyl-5,19-dihydroxy-3-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-14,16-dimethoxy-4,10,12,18-tetramethyl-3,4,5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-octadecahydro-7H-15,19-epoxypyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone; FK-520; FR900520; FR-900520; FR 900520; L 683590; L-683590; L683590; Changchuanmycin; Immunomycin; Ascomycin; Tacrolimus Related Compound A USP; 15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 8-ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-, [3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-. CAS No. 104987-12-4. Pack Sizes: 50 mg. Product ID: BBF-05774. Molecular formula: C43H69NO12. Mole weight: 792. Custom synthesis is available. Send your inquiries for more information. | London |
| Tacrolimus EP Impurity C | Tacrolimus EP Impurity C is an impurity of Tacrolimus, which is a calcineurin inhibitor used as an immunosuppressant after organ transplantation to reduce the activity of the patient's immune system, thereby reducing the risk of organ rejection. Group: Pharmaceutical. Alternative Names: (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-14,16-dimethoxy-4,12,18-trimethyl-8-(prop-2-en-1-yl)-3,4,5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-octadecahydro-7H-15,19-epoxypyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone; 10-Desmethyl tacrolimus; 15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosin. Pack Sizes: 1mg;1g;10g. Product ID: BBF-05742. Molecular formula: C43H67NO12. Mole weight: 789.99. Custom synthesis is available. Send your inquiries for more information. | London |
| Tacrolimus EP Impurity D | Tacrolimus EP Impurity D is an impurity of Tacrolimus, which is a calcineurin inhibitor used as an immunosuppressant after organ transplantation to reduce the activity of the patient's immune system, thereby reducing the risk of organ rejection. Group: Pharmaceutical. Alternative Names: (3S,4R,5S,8S,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-3,4,5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-octadecahydro-7H-15,19-epoxypyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone; 8-epi Tacrolimus; 8-Epitacrolimus; Tacrolimus anhydrous 8-epimer; Tacrol. CAS No. 129212-35-7. Pack Sizes: 1mg;1g;10g. Product ID: BBF-05771. Molecular formula: C44H69NO12. Mole weight: 804.04. Custom synthesis is available. Send your inquiries for more information. | London |
| Tacrolimus EP Impurity E | Tacrolimus EP Impurity E is an impurity of Tacrolimus, which is a calcineurin inhibitor used as an immunosuppressant after organ transplantation to reduce the activity of the patient's immune system, thereby reducing the risk of organ rejection. Group: Pharmaceutical. Alternative Names: (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-propyl-3,4,5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-octadecahydro-7H-15,19-epoxypyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone; Dihydro Tacrolimus; Dihydro-FK 506; 15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotr. CAS No. 104987-30-6. Pack Sizes: 10 mg. Product ID: BBF-05773. Molecular formula: C44H71NO12. Mole weight: 806.06. Custom synthesis is available. Send your inquiries for more information. | London |
| Tacrolimus EP Impurity G | Tacrolimus EP Impurity G is an impurity of Tacrolimus, which is a calcineurin inhibitor used as an immunosuppressant after organ transplantation to reduce the activity of the patient's immune system, thereby reducing the risk of organ rejection. Group: Pharmaceutical. Alternative Names: (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19S,26aS)-5,19-dihydroxy-3-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-3,4,5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-octadecahydro-7H-15,19-epoxypyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone; Tacrolimus compound II; Tacrolimus anhydrous 19-epimer; 19-Epi FK-506; 1. CAS No. 144490-63-1. Pack Sizes: 10 mg. Product ID: BBF-05772. Molecular formula: C44H69NO12. Mole weight: 804.04. Custom synthesis is available. Send your inquiries for more information. | London |
| Tacrolimus EP Impurity H | Tacrolimus EP Impurity H is an impurity of Tacrolimus, which is a calcineurin inhibitor used as an immunosuppressant after organ transplantation to reduce the activity of the patient's immune system, thereby reducing the risk of organ rejection. Group: Pharmaceutical. Alternative Names: (1E,3S,4R,5S,8R,9E,12S,14S)-5-hydroxy-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-14-methoxy-14-[(2R,3S,5R)-3-methoxy-5-methyl-6-oxooxan-2-yl]-2,4,10,12-tetramethyl-7-oxo-8-(prop-2-en-1-yl)tetradeca-1,9-dien-3-yl (2S)-1-formylpiperidine-2-carboxylate; Tacrolimus monohydrate impurity H [EP]; 2-Piperidinecarboxylic acid, 1-formyl-, (1S,2R,3S,6R,7E,10S,12S)-3-hydroxy-1-[(1E)-2-[(1R,3R,4R)-4-hydroxy-. CAS No. 143210-33-7. Pack Sizes: 1mg;1g;10g. Product ID: BBF-05744. Molecular formula: C43H69NO11. Mole weight: 776.01. Custom synthesis is available. Send your inquiries for more information. | London |
| Tacrolimus EP Impurity I | Tacrolimus EP Impurity I is an impurity of Tacrolimus, which is a calcineurin inhibitor used as an immunosuppressant after organ transplantation to reduce the activity of the patient's immune system, thereby reducing the risk of organ rejection. Group: Pharmaceutical. Alternative Names: (3S,4R,5E,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-19-hydroxy-3-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-3,4,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-7H-15,19-epoxypyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone; Tacrolimus diene; 23,24-Anhydro Tacrolimus; Δ23-FK-506; Tacrolimus Impurity I; T. CAS No. 104987-16-8. Pack Sizes: 25 mg. Product ID: BBF-05770. Molecular formula: C44H67NO11. Mole weight: 786.02. Custom synthesis is available. Send your inquiries for more information. | London |
| Tacrolimus Hydroxy Acid Impurity | Tacrolimus Hydroxy Acid Impurity is an impurity of Tacrolimus, which is a calcineurin inhibitor used as an immunosuppressant after organ transplantation to reduce the activity of the patient's immune system, thereby reducing the risk of organ rejection. Group: Pharmaceutical. Alternative Names: Pyrido[2,1-c][1,4]oxaazacyclodocosine-19-carboxylic acid, 1,3,4,5,6,7,8,11,12,13,14,15,16,17,18,19,20,22,23,24,25,25a-docosahydro-5,15,19-trihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-1,7,20-trioxo-8-(2-propen-1-yl)-, (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,25aS)-; (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,25aS)-1,3,4,5,6,7,8,11,12,13,14,15,16,17,18,19,20,22,23,24,25,25a-Docosahydro-5,15,19-trihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-1,7,20-trioxo-8-(2-propen-1-yl)pyrido[2,1-c][1,4]oxaazacyclodocosine-19-carboxylic acid; Tacrolimus α-hydroxy acid; Tacrolimus hydroxy acid. CAS No. 1700657-83-5. Pack Sizes: 25 mg. Product ID: B1370-288687. Molecular formula: C44H71NO13. Mole weight: 822.06. Custom synthesis is available. Send your inquiries for more information. | London |
| Tacrolimus Impurity (Methyl Acryl Aldehyde) | Tacrolimus Impurity (Methyl Acryl Aldehyde) is an impurity of Tacrolimus, which is a calcineurin inhibitor used as an immunosuppressant after organ transplantation to reduce the activity of the patient's immune system, thereby reducing the risk of organ rejection. Group: Pharmaceutical. Alternative Names: (E)-3-[[(1R,3R,4R)-4-Hydroxy-3-methoxycyclohexyl]-2-methylacrylaldehyde; [1R-[1α(E),3α,4β]]-3-(4-Hydroxy-3-methoxycyclohexyl)-2-methyl-2-propenal; Tacrolimus Methylacryl Aldehyde; 3-((1R,3R,4R)-4-Hydroxy-3-methoxycyclohexyl)-2-methylacrylaldehyde, (E)-; (2E)-3-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-2-methylprop-2-enal; (2E)-3-[(1R,3R,4R)-4-Hydroxy-3-methoxycyclohexyl]-2-methylacrylaldehyde; 2-Propenal, 3-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-2-methyl-, (2E)-. CAS No. 109466-74-2. Pack Sizes: 1mg;1g;10g. Product ID: BBF-05775. Molecular formula: C11H18O3. Mole weight: 198.26. Custom synthesis is available. Send your inquiries for more information. | London |
| Tacrolimus monohydrate | Tacrolimus monohydrate is a potent immunosuppressive drug often administered to transplant recipient patients and exhibits a variety of adverse cardiovascular effects. Group: Pharmaceutical. Alternative Names: Tacrolimus Hydrate; Tsukubaenolide hydrate; (3S,?4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine?-1,7,20,21(4H,23H)-tetrone, 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-hydrate. CAS No. 109581-93-3. Pack Sizes: 500 mg. Product ID: BBF-05727. Molecular formula: C44H71NO13. Mole weight: 822.03. Custom synthesis is available. Send your inquiries for more information. | London |
| Tadalafil-[d3] | Tadalafil-[d3] is the labelled analogue of Tadalafil, which is an inhibitor of phosphodiesterase 5 and can be used to treat erectile dysfunction. Tadalafil is also a phosphodiesterase 5 (PDE5) inhibitor. Group: Pharmaceutical. Alternative Names: Tadalafil D3. CAS No. 960226-55-5. Pack Sizes: 10 mg. Product ID: BLP-012605. Molecular formula: C22H16D3N3O4. Mole weight: 392.42. Custom synthesis is available. Send your inquiries for more information. | London |
| Tadalafil EP Impurity I | One of the impurities of Tadalafil, which is an inhibitor of phosphodiesterase 5 and could be used in the treatment of erectile dysfunction. Group: Pharmaceutical. Alternative Names: Tadalafil Spiro-oxindole Impurity; (8a'R)-6'-(1,3-Benzodioxol-5-yl)-2'-methyl-2',3',8',8a'-tetrahydro-6'H-spiro[indole-3,7'-pyrrolo[1,2-a]pyrazine]-1',2,4'(1H)-trione. CAS No. 1795790-92-9. Pack Sizes: 10 mg. Product ID: B2694-482887. Molecular formula: C22H19N3O5. Mole weight: 405.41. Custom synthesis is available. Send your inquiries for more information. | London |
| Tadalafil Impurity B | One of the impurities of Tadalafil, which is an inhibitor of phosphodiesterase 5 and could be used in the treatment of erectile dysfunction. Group: Pharmaceutical. Alternative Names: (6R,12aS)-6-(1,3-benzodioxal-5yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]-1,4-dione. CAS No. 951661-82-8. Pack Sizes: 25 mg. Product ID: B2694-482858. Molecular formula: C20H19N3O3. Mole weight: 349.39. Custom synthesis is available. Send your inquiries for more information. | London |
| Tadalafil Impurity D | One of the impurities of Tadalafil, which is an inhibitor of phosphodiesterase 5 and could be used in the treatment of erectile dysfunction. Group: Pharmaceutical. Alternative Names: (6bR)-12-(1,3-Benzodioxol-5-yl)-12a-hydroxy-8-methyl-6a,6b,8,9,12,12a-hexahydropyrazino[1,2:1,2]-pyrrolo[3,4-c]quinoline-6,7,10(5H)-trione. CAS No. 951661-81-7. Pack Sizes: 5 mg. Product ID: B2694-482857. Molecular formula: C22H20ClN3O4. Mole weight: 425.88. Custom synthesis is available. Send your inquiries for more information. | London |
| Tafamidis | Tafamidis is a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. It is a drug for the amelioration of transthyretin-related hereditary amyloidosis. It functions by kinetic stabilization of the correctly folded tetrameric form of the transthyretin (TTR) protein and binds selectively and with negative cooperativity to the two normally unoccupied thyroxine-binding sites of the tetramer, and kinetically stabilizes TTR. Group: Pharmaceutical. Alternative Names: Fx-1006A; Vyndaqel. CAS No. 594839-88-0. Pack Sizes: 1 g. Product ID: B2693-463292. Molecular formula: C14H7Cl2NO3. Mole weight: 308.12. Custom synthesis is available. Send your inquiries for more information. | London |
| Tafamidis-[d3] | Tafamidis-[d3] is deuterium labelled Tafamidis. Tafamidis is a potent and selective transthyretin (TTR) stabilizer, showing comparable potency and efficacy to the mutumant homotetramers V30M-TTR, V122I-TTR and wild type WT-TTR, with EC50s of 2.7-3.2 μM. Tafamidis inhibits amyloidogenesis. Group: Pharmaceutical. Alternative Names: Tafamidis-d3; d3-Tafamidis. Pack Sizes: 10 mg. Product ID: BLP-014826. Molecular formula: C14H4D3Cl2NO3. Mole weight: 311.13. Custom synthesis is available. Send your inquiries for more information. | London |
| Tafenoquine Succinate | Tafenoquine is a medication for the prevention and treatment of malaria. Group: Pharmaceutical. Alternative Names: WR 238605; WR-238605; WR238605. CAS No. 106635-81-8. Pack Sizes: 200 mg. Product ID: B2692-334165. Molecular formula: C28H34F3N3O7. Mole weight: 581.6. Custom synthesis is available. Send your inquiries for more information. | London |
| Tafluprost | Tafluprost is a novel prostanoid analogue that activates Prostaglandin Receptor. It is used in the treatment of glaucoma and is the first prostanoid to be released in a preservative free-formula. Group: Pharmaceutical. Alternative Names: AFP-168, AFP-168, AFP-168, MK-2452, MK2452, MK 2452, Taflotan; Zioptan; AFP-168; Saflutan; propan-2-yl (Z)-7-[(1R,2R,3R,5S)-2-[(E)-3,3-difluoro-4-phenoxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate. CAS No. 209860-87-7. Pack Sizes: 20 mg. Product ID: B0084-087316. Molecular formula: C25H34F2O5. Mole weight: 452.539. Custom synthesis is available. Send your inquiries for more information. | London |
| Tafluprost ethyl amide | Tafluprost ethyl amide is a highly potent and significant compound utilized in studying the prevalent ocular maladies of glaucoma and ocular hypertension employing a mechanism of action that selectively engages and enhances the outflow of the aqueous humor via specific receptors in the eye. Group: Pharmaceutical. Alternative Names: Taflpostamide; (Z)-7-[(1R,2R,3R,5S)-2-[(E)-3,3-difluoro-4-phenoxybut-1-enyl]-3,5-dihydroxycyclopentyl]-N-ethylhept-5-enamide. CAS No. 1185851-52-8. Pack Sizes: 5 mg. Product ID: B1289-280779. Molecular formula: C24H33F2NO4. Mole weight: 437.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Tagitinim C | Tagitinim C is an antitrypanosomal compound from the moon flower, Tithonia diversifolia. Group: Pharmaceutical. Alternative Names: tagitinin C; (3aR,4R,6R,7E,10Z,11aR)-6-Hydroxy-6,10-dimethyl-3-methylene-2,9-dioxo-2,3,3a,4,5,6,9,11a-octahydrocyclodeca[b]furan-4-yl Isobutyrate. CAS No. 59979-56-5. Pack Sizes: 5 mg. Product ID: B1370-071194. Molecular formula: C19H24O6. Mole weight: 348.4. Custom synthesis is available. Send your inquiries for more information. | London |
| TAK-243 | TAK-243, a pyrazolopyrimidine derivative, has been found to be an Ubiquitin-protein ligase inhibitor and was just finished the Phase-I trial against solid tumors. Group: Pharmaceutical. Alternative Names: TAK-243; TAK 243; TAK243; MLN7243; MLN-7243; MLN 7243; AOB87172; AOB-87172; AOB 87172. CAS No. 1450833-55-2. Pack Sizes: 25 mg. Product ID: B2693-475793. Molecular formula: C19H20F3N5O5S2. Mole weight: 519.51. Custom synthesis is available. Send your inquiries for more information. | London |
| TAK-448 | TAK-448 is a KISS1R protein agonist as a oligopeptide analog of kisspeptin. In animal model, TAK-448 can stimulate LH/FSH release, whereas continuous sc exposure rapidly down-regulates the pituitary-gonadal axis, with rapid reduction of T levels in a dose-dependent manner. Phase II clinical trials for the treatment of Prostate cancer was discontinued. In Dec 2016, Takeda terminated a phase II trial in Hypogonadism (In adults, In the elderly) in USA because the study did not meet the primary endpoints. Uses: Hypogonadism;prostate cancer. Group: Pharmaceutical. Alternative Names: MVT-602; Ac-D-Tyr-D-Trp-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH2; RVT-602; RVT 602; TAK 448; RVT602; TAK448; N-acetyl-D-tyrosyl-(4R)-4-hydroxy-L-prolyl-L-asparaginyl-L-threonyl-L-phenylalanyl-2-azaglycyl-L-leucyl-N5-(imino(methylamino)methyl)-L-ornithyl-L-Tryptophanamide; Istaroxime; (2S,5S,8S,14S,17S,20S)-20-[({(2S,4R)-1-[(2R)-2-Acetamido-3-(4-hydroxyphenyl)propanoyl]-4-hydroxy-2-pyrrolidinyl}carbonyl)amino]-14-benzyl-17-(1-hydroxyethyl)-2-(1H-indol-3-ylmethyl)-8-isobutyl-5-[3-(N'-methylcarbamimidamido)propyl]-4,7,10,13,16,19-hexaoxo-3,6,9,11,12,15,18-heptaazadocosane-1,22-diamide. CAS No. 1234319-68-6. Pack Sizes: 25 mg. Product ID: BAT-010642. Molecular formula: C58H80N16O14. Mole weight: 1225.36. Custom synthesis is available. Send your inquiries for more information. | London |
| TAK-875 | TAK-875 is a potent, selective, and orally bioavailable GPR40 agonist, with a pharmacokinetic profile enabling long-acting drug efficacy. Group: Pharmaceutical. Alternative Names: TAK875; TAK 875; Fasiglifam; 3-Benzofuranacetic acid, 6-[[2',6'-dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]methoxy]-2,3-dihydro-, (3S)-; (3S)-6-[[2',6'-Dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]methoxy]-2,3-dihydro-3-benzofuranacetic acid; (+)-TAK 875; (3S)-6-([2',6'-Dimethyl-4'-[3-(methylsulfonyl)propoxy]biphenyl-3-yl]methoxy)-2,3-dihydro-1-benzofuran-3-yl]acetic acid. CAS No. 1000413-72-8. Pack Sizes: 50 mg. Product ID: B2693-307695. Molecular formula: C29H32O7S. Mole weight: 524.63. Custom synthesis is available. Send your inquiries for more information. | London |
| Talabostat mesylate | Talabostat mesylate is the orally bioavailable mesylate salt of an amino boronic dipeptide with antineoplastic and hematopoiesis- stimulating activities. By cleaving N-terminal Xaa-Pro or Xaa-Ala residues, talabostat inhibits dipeptidyl peptidases, such as fibroblast activation protein (FAP), resulting in the stimulation of cytokine and chemokine production and specific T-cell immunity and T-cell- dependent activity. This agent may also stimulate the production of colony stimulating factors, such as granulocyte colony stimulating factor (G-CSF), resulting in the stimulation of hematopoiesis. Dipeptidyl peptidases are involved in the activation of polypeptide hormones and chemokines. Uses: For research used only. Group: Pharmaceutical. Alternative Names: (R)-1-((S)-2-amino-3-methylbutanoyl)pyrrolidin-2-ylboronic acid methanesulfonic acid (1:1); PT-100; PT100; PT 100; D05989; D-05989; D 05989; Val-boro-pro; Talabostat. CAS No. 150080-09-4. Pack Sizes: 20 mg. Product ID: B0084-084554. Molecular formula: C10H23BN2O6S. Mole weight: 310.17. Custom synthesis is available. Send your inquiries for more information. | London |
| Talatisamine | Talatisamine inhibits the enhanced I(K) caused by Aβ40 oligomers, attenuates cytotoxicity of Aβ oligomers by restoring cell viability and suppressing K(+) loss related apoptotic response. Group: Pharmaceutical. Alternative Names: 20-Ethyl-1α,16β-dimethoxy-4-(methoxymethyl)aconitane-8,14α-diol. CAS No. 20501-56-8. Pack Sizes: 20 mg. Product ID: NP0443. Molecular formula: C24H39NO5. Mole weight: 421.57. Custom synthesis is available. Send your inquiries for more information. | London |
| Talazoparib | Talazoparib, also known as BMN-673, is an orally bioavailable inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) with potential antineoplastic activity. BMN-673 selectively binds to PARP and prevents PARP-mediated DNA repair of single strand DNA breaks via the base-excision repair pathway. BMN-673 has been proven to be highly active in mouse models of human cancer and also appears to be more selectively cytotoxic with a longer half-life and better bioavailability as compared to other compounds in development. Uses: For research used only. Group: Pharmaceutical. Alternative Names: BMN-673; LT-673. BMN 673; LT 673. BMN673; LT673. CAS No. 1207456-01-6. Pack Sizes: 100 mg. Product ID: B0084-462689. Molecular formula: C19H14F2N6O. Mole weight: 380.359. Custom synthesis is available. Send your inquiries for more information. | London |
| (±)-Talinolol | (±)-Talinolol is a β1-selective adrenoceptor antagonist well known for its cardioprotective and antihypertensive activity. By blocking β1-adrenergic receptors, talinolol delays the conduction of stimuli in the AV node, reduces the sino-atrial conduction time, and impedes the sinus node automaticity. Group: Pharmaceutical. Alternative Names: Cordanum; Talinolol. CAS No. 57460-41-0. Pack Sizes: 50 mg. Product ID: B2693-126698. Molecular formula: C20H33N3O3. Mole weight: 363.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Taltirelin | Taltirelin is a thyrotropin-releasing hormone receptor (TRH-R) superagonist with an IC50 of 910 nM and EC50 of 36 nM for stimulating an increase in cytosolic Ca2+ concentration (Ca2+ release). Group: Pharmaceutical. Alternative Names: N-[[(4S)-Hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl]carbonyl]-L-histidyl-L-prolinamide; (S)-N-[(Hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)carbonyl]-L-histidyl-L-prolinamide; (4S)-Hexahydro-1-methyl-2,6-dioxo-4-pyrimidinecarbonyl-L-histidyl-L-prolinamide; Ceredist; TA 0910; (S)-N-((S)-1-((S)-2-Carbamoylpyrrolidin-1-yl)-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl)-1-methyl-2,6-dioxohexahydropyrimidine-4-carboxamide; 1-methyl-(S)-4,5-dihydroorotyl-L-histidyl-L-prolinamide. CAS No. 103300-74-9. Pack Sizes: 1mg;1g;10g. Product ID: BAT-010055. Molecular formula: C17H23N7O5. Mole weight: 405.41. Custom synthesis is available. Send your inquiries for more information. | London |
| Taltirelin Hydrate | Taltirelin hydrate is a thyrotropin-releasing hormone receptor (TRH-R) superagonist with an IC50 of 910 nM and EC50 of 36 nM for stimulating an increase in cytosolic Ca2+ concentration (Ca2+ release). Uses: Nootropic agents. Group: Pharmaceutical. Alternative Names: N-{[(4S)-1-methyl-2,6-dioxohexahydropyrimidin-4-yl]carbonyl}-L-histidyl-L-prolinamide tetrahydrate; (S)-N-[(Hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)carbonyl]-L-histidyl-L-prolinamide tetrahydrate; Ceredist tetrahydrate; TA 0910 tetrahydrate; (S)-N-((S)-1-((S)-2-Carbamoylpyrrolidin-1-yl)-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl)-1-methyl-2,6-dioxohexahydropyrimidine-4-carboxamide tetrahydrate; 1-methyl-(S)-4,5-dihydroorotyl-L-histidyl-L-prolinamide tetrahydrate. CAS No. 201677-75-0. Pack Sizes: 1mg;1g;10g. Product ID: BAT-010056. Molecular formula: C17H31N7O9. Mole weight: 477.46. Custom synthesis is available. Send your inquiries for more information. | London |
| Tamarixetin | Tamarixetin is a natural flavonoid isolated from the herbs of Heracleum stenopterum with anticancer and antiplasmodial activity. Tamarixetin inhibits tumor cell growth, induces apoptosis, and cell cycle arrest. Tamarixetin prevents cardiac hypertrophy by inhibiting the NFAT and AKT pathways. Uses: Anticancer. Group: Pharmaceutical. Alternative Names: 4'-Methoxyquercetin; 4'-O-Methyl Quercetin; 4'-O-Methylquercetin; Quercetin 4'-methyl ether; 3,3',5,7-Tetrahydroxy-4'-methoxyflavonel; 3-O-rhamnopyranosyl-1-2-glucopyranoside. CAS No. 603-61-2. Pack Sizes: 25 mg. Product ID: NP2478. Molecular formula: C16H12O7. Mole weight: 316.26. Custom synthesis is available. Send your inquiries for more information. | London |
| Tameridone | Tameridone is a sedative. Group: Pharmaceutical. Alternative Names: 1H-Purine-2,6-dione, 3,7-dihydro-7-(2-(4-(1H-indol-3-yl)-1-piperidinyl)ethyl)-1,3-dimethyl-. CAS No. 102144-78-5. Pack Sizes: 1mg;1g;10g. Product ID: 102144-78-5. Molecular formula: C22H26N6O2. Mole weight: 406.481. Custom synthesis is available. Send your inquiries for more information. | London |
| Tamibarotene | Tamibarotene is a retinoic acid receptor α (RARα) agonist that induces differentiation and apoptosis of HL-60 cells in vitro. It exhibits antiproliferative effects against a variety of human tumor cells lines and displays anticancer activity against acute promyelocytic leukemia in vivo. It is an orally active, synthetic retinoid, developed to overcome all-trans retinoic acid (ATRA) resistance, with potential antineoplastic activity. It may show sustained plasma levels compared to ATRA. It may exhibit a lower toxicity profile than ATRA, in part, due to the lack of affinity for the RAR-gamma receptor, the major retinoic acid receptor in the dermal epithelium. Group: Pharmaceutical. Alternative Names: Retinobenzoic acid; Amnoid; AMNOLAKE; Am80; Am 80; Am-80; SY-1425; SY 1425; SY1425; Tamibarotene. CAS No. 94497-51-5. Pack Sizes: 1 g. Product ID: B2693-079954. Molecular formula: C22H25NO3. Mole weight: 351.44. Custom synthesis is available. Send your inquiries for more information. | London |
| Tamoxifen-[d5] | One of the labelled form of Tamoxifen, which is an estrogen response modifier as well as protein kinase C inhibitor. Group: Pharmaceutical. Alternative Names: (Z)-1-[4-[2-(Dimethylamino)ethoxy]phenyl]-1,2-diphenyl-1-butene-3,3,4,4,4-d5; (Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine-d5; Z-Tamoxifen-d5. CAS No. 157698-32-3. Pack Sizes: 10 mg. Product ID: BLP-013960. Molecular formula: C26H24D5NO. Mole weight: 376.56. Custom synthesis is available. Send your inquiries for more information. | London |
| Tamsulosin-[d4] hydrochloride | One of the labelled form of Tamsulosin, which is an α1-adrenoceptor antagonist and could be used against benign prostatic hypertrophy. Group: Pharmaceutical. Alternative Names: (R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide-D4 hydrochloride; YM 617-d4; Yutanal-d4. Pack Sizes: 10 mg. Product ID: BLP-006013. Molecular formula: C20H25D4ClN2O5S. Mole weight: 449. Custom synthesis is available. Send your inquiries for more information. | London |
| Tamsulosin hydrochloride | Tamsulosin hydrochloride is a potent and selective prostatic alpha1A adrenergic receptor antagonist for the treatment of benign prostatic hypertrophy. Group: Pharmaceutical. Alternative Names: Benzenesulfonamide, 5-[(2R)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxy-, hydrochloride (1:1); Benzenesulfonamide, 5-[(2R)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxy-, monohydrochloride; Benzenesulfonamide, 5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxy-, monohydrochloride, (R)-; (-)-LY 253352; (-)-YM 12617; (R)-(-)-YM 12617; Dynapress; Flomax; Harnal; LY 253351; Omic; Omnic; URIMAX; URIPRO; YM 12617-1; YM 617; Yutanal; (R)-Tamsulosin Hydrochloride. CAS No. 106463-17-6. Pack Sizes: 5 g. Product ID: B0046-304483. Molecular formula: C20H28N2O5S.HCl. Mole weight: 444.97. Custom synthesis is available. Send your inquiries for more information. | London |
| Tamsulosin Impurity G | One of the impurities of Tamsulosin, which is an α1-adrenoceptor antagonist and could be used against benign prostatic hypertrophy. Group: Pharmaceutical. Alternative Names: (S)-Tamsulosin Hydrochloride; 5-[(2S)-2-[[2-(-Ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide Hydrochloride; (+)-LY 253352. CAS No. 106463-19-8. Pack Sizes: 100 mg. Product ID: B2694-257364. Molecular formula: C20H29ClN2O5S. Mole weight: 444.97. Custom synthesis is available. Send your inquiries for more information. | London |
| Tandospirone | Tandospirone is a potent and selective 5-HT1A receptor partial agonist with Ki of 27 nM. It significantly reduces haloperidol-induced bradykinesia in a dose dependent manner. It also decreased the number of premature responses in a dose-dependent manner. It is used as an antidepressant. Uses: Tandospironeis is used as an antidepressant. Group: Pharmaceutical. Alternative Names: (3aR,4S,7R,7aS)-2-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione; Metanopirone; Sediel; SM-3997; SM 3997; SM3997; 4,7-Methano-1H-isoindole-1,3(2H)-dione, hexahydro-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, (3aa,4b,7b,7aa)-; (3αα,4β,7β,7αα)-Hexahydro-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-4,7-methano-1H-isoindole-1,3(2H)-dione; (3aR,4S,7R,7aS)-rel-Hexahydro-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-4,7-methano-1H-isoindole-1,3(2H)-dionehydrochloride. CAS No. 87760-53-0. Pack Sizes: 25 mg. Product ID: B2693-099721. Molecular formula: C21H29N5O2. Mole weight: 383.49. Custom synthesis is available. Send your inquiries for more information. | London |
| Tandospirone citrate | The citrate salt form of tandospirone, a partial 5HT1A receptors agonist, could be effective as an antianxiety and antidepressant agent. Group: Pharmaceutical. Alternative Names: SM-3997; SM 3997; SM3997. CAS No. 112457-95-1. Pack Sizes: 50 mg. Product ID: B2693-409942. Molecular formula: C21H29N5O2.C6H8O7. Mole weight: 575.61. Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.